Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This includes comprehensive molecular simulations of the receptor in its native membrane environment, paired with ensemble virtual screening that factors in its conformational mobility. In cases involving dimeric or oligomeric receptors, the entire functional complex is modelled, pinpointing potential binding pockets on and between the subunits to capture the full range of mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
Q13002
UPID:
GRIK2_HUMAN
Alternative names:
Excitatory amino acid receptor 4; Glutamate receptor 6
Alternative UPACC:
Q13002; A6NMY9; B5MCV0; D7RWZ3; D7RWZ4; D7RWZ5; D7RWZ6; D7RWZ7; Q8WWS1; Q96KS6; Q96KS7; Q96KS8
Background:
Glutamate receptor ionotropic, kainate 2, also known as Excitatory amino acid receptor 4 or Glutamate receptor 6, plays a pivotal role in the central nervous system as an ionotropic glutamate receptor. It transforms chemical signals into electrical impulses through the binding of L-glutamate, facilitating rapid communication between neurons. Additionally, it exhibits thermoreceptor activity, sensitive to cold temperatures, particularly in dorsal root ganglion neurons.
Therapeutic significance:
This protein is implicated in Intellectual developmental disorder, autosomal recessive 6, and Neurodevelopmental disorder with impaired language and ataxia, both characterized by developmental delays and intellectual challenges. Understanding the role of Glutamate receptor ionotropic, kainate 2 could open doors to potential therapeutic strategies for these neurological conditions.